Exact Sciences said Monday that FDA approved its stool DNA-based colorectal cancer screening test, Cologuard, in average-risk people ages 45 and older, widening the population from its existing indication for people ages 50 and older.
Source: https://www.medtechdive.com/news/fda-lowers-cologuard-age-to-45-adding-19m-to-exacts-screening-market/563482/
